
Cyclerion Therapeutics, Inc.
USD3.00
-0.02 (-0.66%)
CEO
Regina Graul
IPO Date
2019-03-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.00
Prev. Close
$3.02
Day Low
$2.98
Day High
$3.04
52W Low
$1.03
52W High
$8.48
Market Cap
$0.01B
Volume
0.03M
Cyclerion Therapeutics to Present Clinical Trial Design for CY6463 Phase 2a Study in Participants with Alzheimer's Disease with Vascular Pathology at the Alzheimer's Association International Conference 2021 (AAIC)